Adaptive Deep Brain Stimulation: Newer But Not Always Better

Discover how Adaptive Deep Brain Stimulation (aDBS) is revolutionizing the treatment of Parkinson’s disease and movement disorders by providing personalized, real-time brain stimulation. In this insightful discussion, Indu Subramanian, MD and Alfonso Fasano, MD, PhD explore the transition from traditional "brain pacemakers" to sophisticated closed-loop systems. They break down the importance of local field potentials, the role of beta activity in Parkinson’s symptoms, and how new FDA-approved technology allows for automated adjustments to reduce side effects like dyskinesia and gait freezing. This video provides a comprehensive look at the clinical trial data and the promising future of neuromodulation in treating tremors and psychiatric conditions. 00:00 - Introduction to Medscape and Guests 01:03 - Explaining DBS: The Brain Pacemaker 01:46 - Understanding Brain Biomarkers and Beta Activity 03:03 - The Evolution and Approval of Adaptive DBS 04:30 - Applications of aDBS in Psychiatry and Seizures 05:10 - Addressing Tolerance in Tremor Patients 07:41 - Identifying the Ideal Candidate for aDBS 10:04 - Comparing Fast and Slow Adaptive DBS Modes 11:15 - The Future of Automated Brain Stimulation #ParkinsonsDisease #DeepBrainStimulation #Neurology #aDBS #MovementDisorders #MedicalTechnology #Neuromodulation #Medscape #ParkinsonsTreatment #BrainHealth https://www.medscape.com/viewarticle/...